title: Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
authors: Université de Bordeaux, UMR1219, CHU de Bordeaux, 146 Rue Léo Saignat, 33076 Bordeaux Cedex, France.
authors: Pauline
authors: P
authors: Bosco-Lévy
authors: Université de Bordeaux, UMR1219, CHU de Bordeaux, 146 Rue Léo Saignat, 33076 Bordeaux Cedex, France.
authors: Francesco
authors: F
authors: Salvo
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005905:Glyburide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014859:Warfarin; D005905:Glyburide